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Abstract
The field of epigenetics is the study of modifications of DNA and DNA-binding proteins that alter the structure of chromatin without
altering the nucleotide sequence of DNA; some of these modifications may be associated with heritable changes in gene function.
Nutrients play essential roles in the following epigenetic events. First, folate participates in the generation of S-adenosylmethionine, which
acts as a methyl donor in the methylation of cytosines in DNA; methylation of cytosines is associated with gene silencing. Second,
covalent attachment of biotin to histones (DNA-binding proteins) plays a role in gene silencing and in the cellular response to DNA
damage. Third, tryptophan and niacin are converted to nicotinamide adenine dinucleotide, which is a substrate for poly(ADP-ribosylation)
of histones and other DNA-binding proteins; poly(ADP-ribosylation) of these proteins participates in DNA repair and apoptosis. Here we
present a novel procedure to map nutrient-dependent epigenetic marks in the entire genomes of any given species: the combined use of
chromatin immunoprecipitation assays and DNA microarrays. This procedure is also an excellent tool to map the enzymes that mediate
modifications of DNA and DNA-binding proteins in chromatin. Given the tremendous opportunities offered by the combined use of
chromatin immunoprecipitation assays and DNA microarrays, the nutrition community can expect seeing a surge of information related to
roles for nutrients in epigenetic events.
D 2005 Elsevier Inc. All rights reserved.
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1. Introduction
DNA and DNA-binding proteins make up the bulk of
chromatin. DNA-binding proteins comprise a diverse group
of compounds including histones, high-mobility group
proteins, transcription factors and enzymes that mediate
covalent modifications of DNA (see below). Classically, the
nucleotide sequence in DNA has been considered as the sole
driver of heredity. Consistent with this point of view,
phenotypic traits were thought of as being determined by
genetic mutations and recombinations. Recently, this point
of view has been changed dramatically by epigeneticists.
The field of epigenetics is the study of chemical modifica-
tions of DNA and DNA-binding proteins that alter the
structure of chromatin without altering the nucleotide
sequence of the DNA; some of these modifications may
be associated with heritable changes in gene function.
Articles published in the bEmerging IssuesQ series of the
Journal of Nutritional Biochemistry are not intended to
provide readers with an in-depth review of a given topic.
Rather, the purpose of this series is to draw the readers’
attention to recent developments with far-reaching implica-
tions for nutrition sciences. Here we will briefly review
nutrient-dependent epigenetic events and present a novel
tool to study roles for nutrients in epigenetic events: the
combined use of chromatin immunoprecipitation (ChIP)
assays and DNA microarrays.
2. Roles for nutrients in epigenetic events
Most epigenetic mechanisms target DNA and various
DNA-binding proteins. In this section, we review three im-
portant examples for nutrient-dependent epigenetic events.
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2.1. Methylation of DNA
Promoter regions of many genes are rich in CpG
dinucleotides [1]. Carbon 5 of cytosine in CpG dinucleo-
tides is a prime target for methylation by DNA methyl-
transferases (DNMT) [1]. Depending on cell type or tissue,
3–4% of all cytosines in vertebrate DNA and 70% of
cytosines in CpG dinucleotides are 5-methylated [1]. The
following DNMT have been characterized: DNMT1,
DNMT2, DNMT3a, DNMT3b and DNMT3L; catalytic
activity has been shown only for DNMT1, DNMT3a and
DNMT3b [1]. Methylation of cytosines is a heritable
modification of DNA. However, the following mechanisms
are available to remove methylation marks in vivo: (1)
enzyme-mediated removal of methyl groups, although the
enzymes involved have not yet been identified, and (2)
passive removal of methyl groups if methylation is not
maintained at the time of replication [1].
DNMT utilize S-adenosylmethionine as a methyl
donor [1]. Folate plays a unique role in the generation of
S-adenosylmethionine [1]. Briefly, methylentetrahydrofolate
reductase catalyzes the conversion of 5,10-methylenetetra-
hydrofolate to 5-methyltetrahydrofolate. The latter donates a
methyl group to convert homocysteine to methionine.
Methionine adenosyl transferase ligates methionine and
adenosine to produce S-adenosylmethionine. Methylenete-
trahydrofolate reductase deficiency results in hypomethyla-
tion of DNA, consistent with a role for folate in DNA
methylation [1]. Nutrients other than folate also play roles in
one-carbon metabolism: choline and methionine are the
major dietary sources of methyl groups, whereas vitamins
B-6 and B-12, riboflavin and zinc are coenzymes and
cofactors, respectively, for various steps in one-carbon
metabolism [1].
Methylation of CpG islands is associated with transcrip-
tional repression and provides a mean to control gene
expression. DNA methylation plays a role in allele-specific
gene expression (genomic imprinting), heritable transcrip-
tional silencing of parasitic sequence elements and X-
chromosome inactivation [1]. Impaired DNA methylation is
associated with perinatal death, decreased fertility, abnormal
fetal development and tumorigenesis [1].
2.2. Biotinylation of histones
Histones are small proteins (11 to 22 kDa) that mediate
the folding of DNA into chromatin. The following five
major classes of histones have been identified in eukaryotic
cells: H1, H2A, H2B, H3 and H4 [2]. DNA is wrapped
around octamers of core histones, each consisting of one
H3–H3–H4–H4 tetramer and two H2A–H2B dimers, to
form the nucleosomal core particle. Histone H1 associates
with the DNA connecting nucleosomal core particles.
Nucleosomes are stabilized by electrostatic interactions
between negatively charged phosphate groups in DNA
and positively charged q-amino groups (lysine residues) and
guanidino groups (arginine residues) in histones.
Histones consist of a globular C-terminal domain and a
flexible N-terminal tail [2]. The amino terminus of histones
protrudes from the nucleosomal surface; lysines, arginines,
serines and glutamates in the amino terminus are targets for
acetylation, methylation, phosphorylation, ubiquitination,
poly(ADP-ribosylation) and sumoylation [2–6]. These
modifications play important roles in chromatin structure,
regulating processes such as transcriptional activation or
silencing of genes, DNA repair and mitotic and meiotic
condensation of chromatin.
Recently, a novel posttranslational modification of
histones has been identified in human cells: biotinylation
of lysine (K) residues [7]. The following biotinylation sites
have been identified in human histones: K9 and K13 in
histone H2A (unpublished observation); K4, K9 and K18 in
histone H3 [8]; and K8 and K12 in histone H4 [7].
Biotinylation of histones is catalyzed by biotinidase [9]
and holocarboxylase synthetase [10]. Biotinylation of
histones plays a role in processes such as gene silencing,
cell proliferation and DNA repair or apoptosis [11]. Different
kinds of DNA damage cause distinct changes in histone
biotinylation: double-stranded breaks of DNA decrease
histone biotinylation [12], whereas formation of thymine
dimers in DNA increases biotinylation of histones [13].
2.3. Poly(ADP-ribosylation) of histones and other
DNA-binding proteins
Double-stranded DNA breaks require repair by either
nonhomologous end joining or homologous recombination
in order to prevent tumor initiation. If damage is beyond
repair capabilities, apoptosis is triggered to prevent propa-
gation of abnormal cells. Covalent modifications of DNA-
binding proteins play important roles in DNA repair and
apoptosis. Poly(ADP-ribose) polymerase (PARP) binds to
the DNA near strand breaks; binding is associated with
activation of the polymerase. PARP catalyzes the covalent
attachment of linear and branched chains of poly(ADP-
ribose) residues on itself (automodification) and other
acceptor proteins [14]. For example, poly(ADP-ribosyla-
tion) of histones H2A and H2B increases dramatically in
response to DNA breaks [5,15]. Poly(ADP-ribose) chains
may contain N200 ADP-ribose residues [14]. Poly(ADP-
ribosylation) of proteins is a reversible process; degradation
of poly(ADP-ribose) chains is mediated by poly(ADP-
ribose) glycohydrolase [14]. The half-life of poly(ADP-
ribose) in response to DNA damage is b1 min [16].
PARP plays a role in DNA repair, recombination,
apoptosis and maintenance of genomic stability [14,16].
PARP interacts with proteins from the DNA excision repair
machinery [16]. PARP-null mice are extremely sensitive to
genotoxic stressors [16] and are at increased risk for sister
chromatid exchanges.
PARP uses NAD as a substrate for generating poly(ADP-
ribose) chains [16]. In mammals, nicotinamide adenine
dinucleotide (NAD) can be synthesized from either niacin
or tryptophan [17,18]. Consistent with a predominant role for
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niacin in NAD synthesis, poly(ADP-ribosylation) of proteins
correlates with niacin supply in mammals [16]. Niacin
supplementation may reduce the frequency of DNA damage
in human lymphocytes [16].
3. Characterization of epigenetic events by using ChIP
assays and DNA microarrays
Nutritional biochemists can benefit greatly from being in
full command of tools to investigate epigenetic events.
Ground can be lost rapidly in the genomics era by not taking
advantage of cutting-edge technology. Recently, a novel
analytical procedure that is likely to impact the field of
epigenetics dramatically has become available: the combined
use of ChIP assays and DNA microarrays [19,20]. This
procedure is designed to map epigenetic marks in the entire
genome of any given species. This procedure is also an
excellent tool to map the enzymes that mediate modifications
of DNA and DNA-binding proteins in chromatin. The com-
bination of ChIP assays and DNA microarrays holds great
promise for the identification of roles for nutrients in epige-
netic events, given the extraordinary power of this new tool.
What is the working principle of ChIP assays/DNA
microarrays? Briefly, this procedure uses the following
analytical sequence to map epigenetic marks in chromatin
(Fig. 1): (1) DNA and proteins in chromatin are cross-linked
using formaldehyde, and chromatin is sheared to produce
fragments of 500–1500 base pairs in size; (2) chromatin is
immunoprecipitated using an antibody that binds the
epigenetic mark of interest; the supernatant does not contain
the mark of interest and is discarded; (3) DNA is purified
from the precipitated chromatin; (4) DNA is chemically
labeled (e.g., by using fluorophores) and is hybridized to
DNA microarrays; and (5) the epigenetic mark of interest is
mapped in the genome, based on its relative enrichment by
antibody precipitation. The information obtained can be
used in various ways. For example, the relative enrichment
of a given epigenetic mark in a distinct region of chromatin
can be correlated with the transcriptional activity of genes
residing in that region.
The generation of epigenetic road maps in chromatin
depends on the availability of two diagnostic tools: ChIP-
grade antibodies for immunoprecipitations and DNA micro-
arrays that contain probes for both coding and noncoding
regions in the genomes to be investigated. Nowadays, a
relatively large and ever-increasing selection of ChIP-grade
antibodies is available from various commercial sources.
Also, antibodies can be generated by individual investigators
using commercial facilities at reasonable cost. Hence, lack of
appropriate antibodies may not be a limiting factor for most
researchers who are conducting ChIP assays. In contrast, the
current lack of appropriate DNA microarrays hampers
studies described above. The vast majority of DNA micro-
arrays contains probes for coding regions in genomes but
does not contain probes for noncoding regions. Note that
noncoding regions contain the majority of regulatory
sequences of genes and, hence, are the prime target for
many epigenetic modifications. Likely, an increasing num-
ber of DNA microarrays that overcome these early limi-
tations will become available in the near future. Currently,
however, investigators will need to rely on using customized
DNA microarrays, generated either bin houseQ or by
commercial suppliers [21]. Also, some DNA microarrays
that contain probes for both coding and noncoding regions in
the human genome are emerging. For example, Affymetrix,
Inc.1 has developed a DNA microarray that contains probes
Fig. 1. Creating epigenetic road maps by using ChIP assays in combination with DNA microarrays.
1 Mention of trade names or commercial products in this article is
solely for the purpose of providing specific information and does not imply
recommendation or endorsement by the US Department of Agriculture.
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for coding and noncoding regions from the entire human
chromosomes 21 and 22 [22]. Finally, investigators may
want to consider using alternative techniques such as
bchromatin immunoprecipitation arbitrarily primed PCR
assay,Q in which immunoprecipitated DNA is amplified
using random GC-rich or non-GC-rich primers to allow for
random analysis of the entire genome [23].
The experimental procedures outlined here are likely to
generate knowledge in areas pertinent to human health. For
example, cancer is a manifestation of both abnormal genetic
and epigenetic events. The combined use of ChIP assays
and DNA microarrays is an excellent approach to investi-
gate anticancer roles for nutrients such as folate, biotin and
niacin based on the evidence provided above. Likewise,
ChIP assays and DNA microarrays are a unique tool to
investigate roles for nutrients in gene silencing during
embryonic development.
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